Aspirin may decrease the risk of developing cancer, according to the study conducted by a binational team led by researchers at Massachusetts General Hospital (MGH), the Berman Center in Minnesota, and Monash University in Australia. Compelling evidence from clinical trials that included predominantly middle-aged adults demonstrates that aspirin may reduce the risk of developing cancer,…
Patients receiving interleukin-1£] (IL-1£]) inhibitors had lower rates of total hip or total knee replacements over an average follow up of 3.7 years, according to an exploratory analysis of data from the CANTOS (Canakinumab Anti-inflammatory Thrombosis Outcomes Study), which is a randomized double-blind, placebo-controlled trial. These findings are important, as no treatments currently exist that…
Highlights: World Hepatitis Day is celebrated annually on 28th July to create awareness on the global burden of viral hepatitis Around 290 million people are living with viral hepatitis unaware worldwide The theme for 2020 is ‘Find The Missing Millions’. World Hepatitis Day is celebrated annually on July 28th.Organizations around the world celebrate World Hepatitis…
The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has given a thumbs up to two new oncology drugs. The Committee has recommended granting conditional marketing authorization for avapritinib (Ayvakit, Blueprint Medicines) for use in adults with unresectable or metastatic gastrointestinal stromal tumors (GIST) harboring a platelet-derived growth factor receptor alpha (PDGFRA) exon 18 mutation,…
Significant advances in the management of eye cancer mean that early referrals to subspecialists are crucial when ophthalmologists suspect disease in their patients, two leaders in the field say. “Don’t be afraid or embarrassed to contact an ocular oncologist,” said Carol Shields, MD, from Wills Eye Hospital in Philadelphia. Improvements in prognosis and treatment are…
As more jurisdictions mandate facial coverings in public, questions have arisen about whether it’s safe for everyone — including those with lung disease — to wear masks. Stories about people who claim to be unable to wear masks because of breathing problems are appearing in the news with increasing frequency, and patients are starting to call their…
As the world reels under the growing coronavirus cases, Russia’s Sechenov University has successfully completed the world’s first clinical trials of COVID-19 vaccine on humans. Chief researcher Elena Smolyarchuk, who heads the Center for Clinical Research on Medications at Sechenov University, told Russian news agency TASS on Sunday that the human trials for the vaccine…
For its Solidarity Trial, the World Health Organization (WHO) has announced that it was discontinuing hydroxychloroquine and lopinavir/ritonavir, citing little or no reduction in the mortality of hospitalized COVID-19 patients. The WHO said the decision was in light of the evidence from the Solidarity Trial interim results. “These interim trial results show that hydroxychloroquine and…
Obese and overweight breast cancer patients might benefit less from docetaxel compared to lean patients, according to retrospective analysis of data from a large clinical trial, published in the Journal of Clinical Oncology. In most European countries, more than 50% of women are overweight or obese (with a body mass index (BMI) above 25 kg/m2, as…
Patients who received a liver transplant that is infected with hepatitis C can clear the virus infection later and have a safe recovery as patients who received an organ free of infection, reports a new study. The findings of the study are published in the journal Liver Transplantation. Two sets of 32 patients were enrolled in…
